223 related articles for article (PubMed ID: 16204043)
21. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
22. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
23. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
Rhiem K; Todt U; Wappenschmidt B; Klein A; Wardelmann E; Schmutzler RK
Anticancer Res; 2010 Sep; 30(9):3445-9. PubMed ID: 20944121
[TBL] [Abstract][Full Text] [Related]
24. ATM heterozygosity and cancer risk.
Concannon P
Nat Genet; 2002 Sep; 32(1):89-90. PubMed ID: 12205473
[No Abstract] [Full Text] [Related]
25. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
26. Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland.
Deans AJ; Simpson KJ; Trivett MK; Brown MA; McArthur GA
Oncogene; 2004 Aug; 23(36):6136-45. PubMed ID: 15208652
[TBL] [Abstract][Full Text] [Related]
27. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.
Shen KC; Heng H; Wang Y; Lu S; Liu G; Deng CX; Brooks SC; Wang YA
Cancer Res; 2005 Oct; 65(19):8747-53. PubMed ID: 16204044
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity.
Wang J; Su F; Smilenov LB; Zhou L; Hu W; Ding N; Zhou G
Radiat Oncol; 2011 Aug; 6():96. PubMed ID: 21849032
[TBL] [Abstract][Full Text] [Related]
29. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
30. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
31. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
32. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
[TBL] [Abstract][Full Text] [Related]
33. Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1.
Kim SS; Cao L; Baek HJ; Lim SC; Li C; Wang RH; Xu X; Cho KH; Deng CX
Cancer Res; 2009 Dec; 69(24):9291-300. PubMed ID: 19996295
[TBL] [Abstract][Full Text] [Related]
34. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
Gurley KE; Kemp CJ
Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
[TBL] [Abstract][Full Text] [Related]
35. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.
Spring K; Cross S; Li C; Watters D; Ben-Senior L; Waring P; Ahangari F; Lu SL; Chen P; Misko I; Paterson C; Kay G; Smorodinsky NI; Shiloh Y; Lavin MF
Cancer Res; 2001 Jun; 61(11):4561-8. PubMed ID: 11389091
[TBL] [Abstract][Full Text] [Related]
36. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
Deng CX; Scott F
Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
[TBL] [Abstract][Full Text] [Related]
37. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
38. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
39. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation.
Hishiya A; Ito M; Aburatani H; Motoyama N; Ikeda K; Watanabe K
Bone; 2005 Oct; 37(4):497-503. PubMed ID: 16027059
[TBL] [Abstract][Full Text] [Related]
40. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.
Gueven N; Luff J; Peng C; Hosokawa K; Bottle SE; Lavin MF
Free Radic Biol Med; 2006 Sep; 41(6):992-1000. PubMed ID: 16934683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]